Russell Investments Group Ltd. Has $376.17 Million Stock Holdings in Johnson & Johnson $JNJ

26 Nov 2025, 09:58 by Doug Wharley · The Cerbat Gem

Russell Investments Group Ltd. lowered its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.4% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,463,395 shares of the company’s stock after selling 140,579 shares during the period. Johnson & Johnson comprises about 0.5% of Russell Investments Group Ltd.’s investment portfolio, making the stock its 21st biggest holding. Russell Investments Group Ltd. owned 0.10% of Johnson & Johnson worth $376,173,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of JNJ. W.H. Cornerstone Investments Inc. raised its stake in shares of Johnson & Johnson by 0.7% during the 2nd quarter. W.H. Cornerstone Investments Inc. now owns 7,896 shares of the company’s stock worth $1,206,000 after purchasing an additional 58 shares in the last quarter. YANKCOM Partnership boosted its holdings in shares of Johnson & Johnson by 0.8% during the 2nd quarter. YANKCOM Partnership now owns 7,042 shares of the company’s stock worth $1,076,000 after buying an additional 58 shares during the period. Greenup Street Wealth Management LLC grew its stake in Johnson & Johnson by 3.1% in the 2nd quarter. Greenup Street Wealth Management LLC now owns 2,021 shares of the company’s stock valued at $309,000 after buying an additional 60 shares during the last quarter. Ellis Investment Partners LLC lifted its position in Johnson & Johnson by 0.7% during the 2nd quarter. Ellis Investment Partners LLC now owns 8,559 shares of the company’s stock worth $1,307,000 after acquiring an additional 62 shares during the last quarter. Finally, Cypress Wealth Services LLC increased its stake in shares of Johnson & Johnson by 0.9% in the second quarter. Cypress Wealth Services LLC now owns 6,634 shares of the company’s stock worth $1,013,000 after purchasing an additional 62 shares during the period. 69.55% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Johnson & Johnson

In other news, EVP Jennifer L. Taubert sold 56,471 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $177.81, for a total value of $10,041,108.51. Following the sale, the executive vice president directly owned 178,013 shares in the company, valued at approximately $31,652,491.53. This trade represents a 24.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.16% of the company’s stock.

Johnson & Johnson Stock Up 0.3%

Johnson & Johnson stock opened at $206.66 on Wednesday. The stock has a market cap of $497.91 billion, a P/E ratio of 19.95, a P/E/G ratio of 2.19 and a beta of 0.38. The company’s 50-day moving average price is $189.43 and its two-hundred day moving average price is $172.50. The company has a quick ratio of 0.80, a current ratio of 1.07 and a debt-to-equity ratio of 0.50. Johnson & Johnson has a twelve month low of $140.68 and a twelve month high of $207.72.

Johnson & Johnson (NYSE:JNJ – Get Free Report) last released its earnings results on Wednesday, August 30th. The company reported $2.26 earnings per share (EPS) for the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%.The company had revenue of $24.02 billion for the quarter. As a group, analysts expect that Johnson & Johnson will post 10.58 EPS for the current year.

Johnson & Johnson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 25th will be paid a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, November 25th. This represents a $5.20 annualized dividend and a yield of 2.5%. Johnson & Johnson’s payout ratio is presently 50.19%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Cowen reaffirmed a “buy” rating on shares of Johnson & Johnson in a report on Tuesday, October 14th. Bank of America raised their price objective on shares of Johnson & Johnson from $198.00 to $204.00 and gave the stock a “neutral” rating in a report on Wednesday, October 15th. UBS Group upped their target price on shares of Johnson & Johnson from $190.00 to $214.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. Daiwa Capital Markets raised shares of Johnson & Johnson from a “neutral” rating to an “outperform” rating and set a $203.00 price target for the company in a research note on Monday, October 20th. Finally, HSBC increased their target price on Johnson & Johnson from $210.00 to $215.00 and gave the company a “buy” rating in a research note on Thursday, October 16th. Four investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Johnson & Johnson has a consensus rating of “Moderate Buy” and an average price target of $201.05.

Get Our Latest Analysis on Johnson & Johnson

About Johnson & Johnson

(Free Report)